InnoCare Releases 2025 Results and Business Highlights, Achieving First Annual Profit
- Written by The Bulletin
BEIJING, CHINA - EQS Newswire - 26 March 2026 - InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual results for 2025 as of December 13, 2025.
Read more: InnoCare Releases 2025 Results and Business Highlights, Achieving First Annual Profit













